Gerd G.
- Country
- Germany
- Department
- Dres. Graffunder, Lais, Perlova-Griff, Schein
Research Overview
Data & Insights
Has run more than one trial at 57 of 229 partner sites.
Specializations
Breast Cancer Treatment
The investigator specializes in the treatment of hormone receptor-positive (HR+) and HER2-negative breast cancer, with particular focus on developing innovative therapeutic approaches in early-stage disease management.
- Early Breast Cancer (EBC) Therapies
- Endocrine Therapy Optimization
- Adjuvant Treatment Strategies
Research interests extend to evaluating novel therapeutic combinations to enhance treatment outcomes in breast cancer patients.
Genetic Oncology
The investigator focuses on treatment approaches for patients with germline BRCA mutations in breast cancer, exploring targeted therapeutic interventions for this specific genetic profile.
- BRCA-Mutated Cancer Treatment
- High-Risk Breast Cancer Management
- Targeted Therapy Development
Expertise includes developing personalized treatment strategies based on genetic markers in breast cancer.
Disease-Free Survival Studies
The investigator conducts research focusing on invasive disease-free survival (iDFS) outcomes in breast cancer patients, evaluating various therapeutic interventions and their long-term effectiveness.
- Long-term Treatment Outcomes
- Survival Rate Analysis
- Treatment Duration Assessment
Work encompasses monitoring and analyzing treatment efficacy through disease-free survival metrics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.